Literature DB >> 11739224

Recent advances: Respiratory medicine.

H A Kerstjens1, H J Groen, W van Der Bij.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11739224      PMCID： PMC1121808          DOI： 10.1136/bmj.323.7325.1349

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  32 in total

1.  Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

Authors:  H Milgrom; R B Fick; J Q Su; J D Reimann; R K Bush; M L Watrous; W J Metzger
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

2.  Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.

Authors:  E R Bleecker; M J Welch; S F Weinstein; C Kalberg; M Johnson; L Edwards; K A Rickard
Journal:  J Allergy Clin Immunol       Date:  2000-06       Impact factor: 10.793

3.  Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.

Authors:  J C Virchow; A Prasse; I Naya; L Summerton; A Harris
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

4.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

5.  Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.

Authors:  M Laviolette; K Malmstrom; S Lu; P Chervinsky; J C Pujet; I Peszek; J Zhang; T F Reiss
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

6.  Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

Authors:  L C Borish; H S Nelson; M J Lanz; L Claussen; J B Whitmore; J M Agosti; L Garrison
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

7.  Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease.

Authors:  G J Criner; F C Cordova; S Furukawa; A M Kuzma; J M Travaline; V Leyenson; G M O'Brien
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

Review 8.  Self-management education and regular practitioner review for adults with asthma.

Authors:  P G Gibson; J Coughlan; A J Wilson; M Abramson; A Bauman; M J Hensley; E H Walters
Journal:  Cochrane Database Syst Rev       Date:  2000

9.  Effect of lung-volume-reduction surgery in patients with severe emphysema.

Authors:  D Geddes; M Davies; H Koyama; D Hansell; U Pastorino; J Pepper; P Agent; P Cullinan; S J MacNeill; P Goldstraw
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

10.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

Authors:  R M Pieterman; J W van Putten; J J Meuzelaar; E L Mooyaart; W Vaalburg; G H Koëter; V Fidler; J Pruim; H J Groen
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245
View more
  2 in total

Review 1.  Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease.

Authors:  Zafar A Usmani; Kristin V Carson; Karen Heslop; Adrian J Esterman; Anthony De Soyza; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-03-21

2.  Octogenarian patients with colon cancer - postoperative morbidity and mortality are the major challenges.

Authors:  Øystein Høydahl; Tom-Harald Edna; Athanasios Xanthoulis; Stian Lydersen; Birger Henning Endreseth
Journal:  BMC Cancer       Date:  2022-03-21       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.